Erik Nutma

130 Chapter 5 101. doi:10.2174/1872214811307020002 26. Papadopoulos V. Peripheral-type benzodiazepine/ diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr Rev. Apr 1993;14(2):222-40. doi:10.1210/edrv-14-2-222 27. Veenman L, et al. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther. Jun 2006;110(3):503-24. doi:10.1016/j.pharmthera.2005.09.007 28. Galiegue S, et al. Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival. Clin Cancer Res. Mar 15 2004;10(6):2058-64. doi:10.1158/1078-0432.ccr-03-0988 29. Tonon MC, et al. Endozepines and their receptors: Structure, functions and pathophysiological significance. Pharmacol Ther.Apr2020;208:107386. doi:10.1016/j.pharmthera.2019.06.008 30. Chen MK, et al. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. Apr 2008;118(1):1-17. doi:10.1016/j.pharmthera.2007.12.004 31. Taliani S, et al. Translocator protein ligands as promising therapeutic tools for anxiety disorders. Curr Med Chem. 2009;16(26):3359-80. doi:10.2174/092986709789057653 32. Liu GJ, et al. The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol. Nov 2014;24(6):631-53. doi:10.1111/bpa.12196 33. Wang HJ, et al. Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription. Cell Tissue Res. Nov 2012;350(2):261-75. doi:10.1007/s00441-0121478-5 34. Bribes E, et al. Immunohistochemical assessment of the peripheral benzodiazepine receptor in human tissues. J Histochem Cytochem. Jan 2004;52(1):1928. doi:10.1177/002215540405200103 35. Katz Y, et al. Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin Sci (Lond). Feb 1990;78(2):1558. doi:10.1042/cs0780155 36. Bhoola NH, et al. Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers. Int J Mol Sci. Jul 25 2018;19(8)doi:10.3390/ijms19082176 37. HanZ, et al. Expressionof peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. J Recept Signal Transduct Res. 2003;23(2-3):22538. doi:10.1081/rrs-120025210 38. Batarseh A, et al. Functional characterization of the human translocator protein (18kDa) gene promoter in human breast cancer cell lines. Biochim Biophys Acta. Jan 2012;1819(1):38-56. doi:10.1016/j. bbagrm.2011.09.001 39. Hardwick M, et al. Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cells. Cancer Genet Cytogenet. Nov 2002;139(1):48-51. doi:10.1016/ s0165-4608(02)00604-0 40. Anholt RR, et al. Theperipheral-typebenzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem. Jan 15 1986;261(2):57683. 41. Garnier M, et al. Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology. Jan 1993;132(1):444-58. doi:10.1210/ endo.132.1.8380386 42. Hardwick M, et al. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBRmediated cell proliferation and nuclear transport of cholesterol. Cancer Res. Feb 15 1999;59(4):831-42. 43. Doble A, et al. Photoaffinity labeling of peripheraltype benzodiazepine-binding sites. Mol Pharmacol. Jan 1987;31(1):42-9. 44. Antkiewicz-Michaluk L, et al. Purification and characterization of a protein associated with peripheral-type benzodiazepine binding sites. J Biol Chem. Nov 25 1988;263(33):17317-21. 45. Riond J, et al. Characterization of a peripheral-type benzodiazepine-binding site in the mitochondria of Chinese hamster ovary cells. FEBS Lett. Mar 13 1989;245(1-2):238-44. doi:10.1016/00145793(89)80229-7 46. Sprengel R, et al. Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor. J Biol Chem. Dec 5 1989;264(34):2041521. 47. Riond J, et al. Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur J Biochem. Jan 30 1991;195(2):305-11. doi:10.1111/j.1432-1033.1991.tb15707.x 48. Chang YJ, et al. The human “peripheral-type” benzodiazepine receptor: regional mapping of the gene and characterization of the receptor expressed from cDNA. DNA Cell Biol. Jul-Aug 1992;11(6):471-80. doi:10.1089/dna.1992.11.471 49. Parola AL, et al. Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquinoline binding protein. J Biol Chem. Jul 25 1991;266(21):14082-7. 50. Garnier M, et al. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. Mol Pharmacol. Feb 1994;45(2):201-11. 51. McEnery MW, et al. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci U S A. Apr 15

RkJQdWJsaXNoZXIy MTk4NDMw